Flex Pharma names William McVicar as president and CEO
Flex Pharma announced that the Board of Directors has appointed William McVicar, Ph.D., as President and CEO. McVicar joined Flex Pharma in April as President of Research & Development. In June, McVicar was appointed interim President and CEO with Christoph Westphal, M.D., Ph.D. continuing to serve as Chairman of the Board of Flex Pharma. "Following a thorough search process, Bill emerged as the best leader for the company as it enters this important phase of clinical execution," said Dr. Rod MacKinnon, Nobel laureate and Flex Pharma Scientific Co-Founder, Board Member, and Scientific Advisory Board Co-Chair. "Flex Pharma is well positioned for clinical and operational success. I have full confidence in Bill to lead the continued advancement of our potentially life-altering therapies through the necessary regulatory pathways and ultimately deliver to the patients who currently have no safe and effective options."